S.V. Kirillov

1.4k citations
46 papers · 1.2k indexed · h-index 22
Topics
RNA and protein synthesis mechanisms (44 papers)RNA modifications and cancer (34 papers)Peptidase Inhibition and Analysis (8 papers)

In The Last Decade

S.V. Kirillov

44 papers receiving 1.2k citations

Peers

S.V. Kirillov
Comparison fields: 5 of 74
  • Molecular Biology 1.1k
  • Genetics 233
  • Oncology 138
  • Ecology 91
  • Cardiology and Cardiovascular Medicine 61
Replace K.H. Nierhaus with:
K.H. Nierhaus Germany
Peter Frank United States
Rolf Bald Germany
Emanuel J. Murgola United States
Ute Kothe Canada
J.P. Ebel France
N. Demeshkina Russia
J. Dondon France
Ingo Wohlgemuth Germany
Catherine D. Prescott United Kingdom
S.V. Kirillov relative to K.H. Nierhaus Germany K.H. Nierhaus's profile →
Citations per field
00.5×
K.H. Nierhaus · 1×
Citations per year

Countries citing papers authored by S.V. Kirillov

Since Specialization
Citations

This map shows the geographic impact of S.V. Kirillov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.V. Kirillov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.V. Kirillov more than expected).

Fields of papers citing papers by S.V. Kirillov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.V. Kirillov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.V. Kirillov. The network helps show where S.V. Kirillov may publish in the future.

Co-authorship network of co-authors of S.V. Kirillov

This figure shows the co-authorship network connecting the top 25 collaborators of S.V. Kirillov. A scholar is included among the top collaborators of S.V. Kirillov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.V. Kirillov. S.V. Kirillov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 32
4 160
5 14
6 51
7 34
8 22
9 45
10 29
11 20
12 49
13 32
14 12
15 13
16 20
17 12
18 25
19 32
20 26

About S.V. Kirillov

S.V. Kirillov is a scholar working on Molecular Biology, Oncology and Genetics, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (44 papers), RNA modifications and cancer (34 papers) and Peptidase Inhibition and Analysis (8 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Genetics (233 citations) and Oncology (138 citations). S.V. Kirillov has collaborated with scholars based in Russia, United States and Denmark. Frequent co-authors include Yu.P. Semenkov, V.I. Makhno, Barry S. Cooperman, Dongli Pan, Evgeny M. Makarov, Yuri P. Semenkov, Bo Porse, Roger A. Garrett, Ya‐Ming Hou and Vladimir I. Katunin. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026